Table 2.
Specification of antibodies used in this study
| Method | CD # | Name | Company | Clone | Isotype | Fluorochrome |
|---|---|---|---|---|---|---|
| FC | 2 | T11, LFA-2 | BD-Pharmingen | RPA-2.10 | mIgG1 | PE |
| FC | 9 | BA2 | Immunotech | ALB 6 | mIgG1 | FITC |
| FC | 25 | IL-2RA | BD-Pharmingen | 2A3 | mIgG1 | PE |
| FC | 30 | TNFRSF8 | BD-Pharmingen | BerH8 | mIgG1 | PE |
| FC | 31 | PECAM-1 | Miltenyi Biotec | AC128 | mIgG1 | APC |
| FC | 44 | CDW44 | BD-Pharmingen | 515 | mIgG1 | PE |
| FC | 54 | ICAM-1 | Immunotech | 84H10 | mIgG1 | FITC |
| FC | 58 | LFA3 | Immunotech | AICD58 | mIgG2a | FITC |
| FC | 62E | Selectin E | BD-Pharmingen | 68-5H11 | mIgG1 | PE |
| FC | 62L | Selectin L | BD-Pharmingen | DREG-56 | mIgG1 | PE |
| FC | 62P | Selectin P | BD-Pharmingen | AK-4 | mIgG1 | PE |
| FC | 63 | LAMP-3 | Immunotech | CLB-gran12 | mIgG1 | PE |
| FC | 117 | Kit | BD-Pharmingen | 104D2D1 | mIgG1 | PE |
| FC | 162 | Selectin P ligand | BD-Pharmingen | KPL-1 | mIgG1 | PE |
| FC | – | Isotype | BD-Pharmingen | MOPC-21 | mIgG1 | FITC |
| FC | – | Isotype | BD-Pharmingen | MOPC-21 | mIgG1 | PE |
| FC | – | Isotype | BD-Pharmingen | X39 | mIgG2a | FITC |
| ICC | 2 | T11, LFA-2 | Novocastra | AB75 | IgG1 | n.a. |
| ICC | 25 | IL-2RA | Novocastra | 4C9 | IgG2b | n.a. |
| ICC | 34 | – | Novocastra | QBEnd/10 | IgG1 | n.a. |
| ICC | 177 | Kit | Dako | Polyclonal | n.a. | n.a. |
| ICC | – | HDC | Progen | Polyclonal | n.a. | n.a. |
| ICC | – | Tryptase | Dako | AA1 | IgG1 | n.a. |
| ICC | – | Chymase | Chemicon | B7 | IgG1 | n.a. |
FC, flow cytometry; ICC, immunocytochemistry; FITC, fluorescein isothiocyanate; PE, phycoerythrin; APC, allophycocyanin; n.a., not applicable; HDC, histidine decarboxylase.